InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by ROGERS MICHAEL W, Director. Director active across 1 companies, notably Akebia Therapeutics, Inc.. Cumulatively, 3 disclosures have been published. The latest transaction was filed on 8 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
013,700 shares0
Common Stock
SEC:0001562180-22-004976:0·
013,700 shares0
Common Stock
SEC:0001562180-21-004029·
013,700 shares0
Common Stock
SEC:0001562180-21-004029:0·
3 of 3 declarations
About ROGERS MICHAEL W
Michael W. Rogers is a Director at Akebia Therapeutics, Inc. As a board member, he participates in the governance of the company and in strategic decision-making. Akebia Therapeutics is a biopharmaceutical company focused on developing innovative treatments for kidney diseases. Michael W. Rogers brings valuable experience in the sector, contributing to the strategic direction of the company.
